Debut Plus

17.54

+1.26 +7.74%

10 Sept 2026

NSE Listed

Anlon Healthcare Limited (AHCL)

Volume: 3,16,29,564Avg Vol 1W: 1,09,53,861Avg Vol 1M: 55,96,823.9552W Range:9.8718
Key Ratios
Checked 3h ago
Market Cap₹932 Cr
Current Price₹17.54
Previous Close₹16.28
High / Low (52w)₹18 / ₹9.87
Volume3,16,29,564
Avg Vol (1W)1,09,53,861
Avg Vol (1M)55,96,823.95
Stock P/E29.23
Book Value₹4.33
Dividend Yield0%
ROE12.39%
ROA9.04%
Revenue (TTM)₹172 Cr
Revenue Growth
Profit Margin13.98%
Total Debt₹44 Cr
Shares Outstanding53 Cr
Face Value₹10
EPS (TTM)₹0.6
P/B4.05
Debt / Equity0.35
50 DMA₹15.14
200 DMA₹13.93
Day change+7.74%
Price Chart
17.54 64.54% · 1Y
18115.1Cr
2025-09-10
2026-09-10

20-day avg volume: 56.0L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 72% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026Jun 2026
Revenue₹38 Cr₹24 Cr₹9 Cr₹49 Cr₹33 Cr₹36 Cr₹51 Cr₹88 Cr
EBITDA₹6 Cr₹7 Cr₹1 Cr₹16 Cr₹6 Cr₹12 Cr₹15 Cr₹15 Cr
Net Profit₹5 Cr₹3 Cr₹-2 Cr₹17 Cr₹4 Cr₹5 Cr₹11 Cr₹7 Cr
EPS2.830.41-0.83
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹49 Cr₹120 Cr₹33 Cr₹52 Cr₹36 Cr₹55 Cr₹172 Cr₹31 Cr
EBITDA₹16 Cr₹31 Cr₹6 Cr₹13 Cr₹12 Cr₹14 Cr₹46 Cr₹7 Cr
Net Profit₹17 Cr₹21 Cr₹4 Cr₹9 Cr₹5 Cr₹10 Cr₹29 Cr₹5 Cr
EPS6.376.11
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹71 Cr₹85 Cr₹112 Cr₹128 Cr₹181 Cr₹374 Cr
Total Liabilities₹69 Cr₹83 Cr₹104 Cr₹107 Cr₹101 Cr₹119 Cr
Equity₹2 Cr₹2 Cr₹7 Cr₹21 Cr₹80 Cr₹255 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-15 Cr₹-2 Cr₹-3 Cr₹-3 Cr₹-27 Cr₹-54 Cr
Investing₹-2 Cr₹0 Cr₹0 Cr₹-3 Cr₹3 Cr₹-36 Cr
Financing₹16 Cr₹3 Cr₹2 Cr₹8 Cr₹19 Cr₹118 Cr
Free Cash Flow₹-15 Cr₹-2 Cr₹-3 Cr₹-3 Cr₹-27 Cr₹-54 Cr
Shareholding
Promoter 52.68% Institutions 2.89% Public 44.43%
Efficiency & Working Capital
ROCE16.9%
Interest Coverage12.4
Dividend Payout
Debtor Days220 d
Inventory Days240 d
Payable Days90 d
Cash Conversion Cycle371 d
Working Capital Days460 d
Shareholding Details

As of 2026-06-30

Promoter52.7%
FII1.7%
DII1.2%
Institutions2.9%
Public44.4%
Promoter Pledge0%
No. of Shareholders34,671
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodOct 2024Oct 2024Apr 2025Apr 2025Jun 2025Aug 2025Aug 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters70.3%70.3%70.3%70.3%52.7%70.3%70.3%52.7%52.7%52.7%52.7%
FIIs0%0%0%0%14.4%0%0%0%0.2%0.3%1.7%
DIIs29.7%0%29.7%0%4.3%29.7%0%2.8%4.5%4.6%1.2%
Public0%29.7%0%29.7%28.6%0%29.7%44.5%42.6%42.4%44.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1091091311319,12513513512,46411,41212,48434,671
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Punitkumar R RasadiaShareholding of Promoter and Promoter Group35%18.59 Cr
Meet Atulkumar VachhaniShareholding of Promoter and Promoter Group17.7%9.41 Cr
Shree Dwarikadhish Ventures LlpPublic Shareholding7.5%4.00 Cr
Ban Labs Private LimitedPublic Shareholding5.3%2.80 Cr
Luv Natwarlal UkaniPublic Shareholding1.1%60,00,000
Harshad Rasiklal ShethPublic Shareholding1.1%60,00,000
Jay Mauleshkumar UkaniPublic Shareholding1.1%60,00,000
Mamata Punitkumar RasadiaShareholding of Promoter and Promoter Group0%0
Rasadia Bhanumati RameshbhaiShareholding of Promoter and Promoter Group0%0
Shilpaben Meetbhai VachhaniShareholding of Promoter and Promoter Group0%0
Rasadia Khush PunitkumarShareholding of Promoter and Promoter Group0%0
Rameshbhai Maganbhai RamotiyaShareholding of Promoter and Promoter Group0%0
Ramotiya RamabenShareholding of Promoter and Promoter Group0%0
Jayesh Rameshbhai RamotiyaShareholding of Promoter and Promoter Group0%0
Sanjay Ramotiya RShareholding of Promoter and Promoter Group0%0
Atulbhai Shyamlal VachhaniShareholding of Promoter and Promoter Group0%0
Vachhani Bhartiben AtulbhaiShareholding of Promoter and Promoter Group0%0
Neha Nirmal PatelShareholding of Promoter and Promoter Group0%0
Gyana Meetbhai VachhaniShareholding of Promoter and Promoter Group0%0
Vari Meetbhai VachhaniShareholding of Promoter and Promoter Group0%0
Anlon Chemical Research OrganizationShareholding of Promoter and Promoter Group0%0
Anlon Lifescience Private LimitedShareholding of Promoter and Promoter Group0%0
Advintel Medicare Private LimitedShareholding of Promoter and Promoter Group0%0
Ramotiya Maganbhai Rameshbhai HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Punitkumar R RasadiaChairman / Executive Director / M D / Promoter2025
Meet Atulkumar VachhaniWTD & Executive Director2025
Mamata Punitkumar RasadiaNon-Exec & Non-Independent Dir2025
Kannepalli Krishna MurtyIndependent Non Exe. Director2025
Anandbhai Natwerlal KatkoriaIndependent Non Exe. Director2025
Pragada Amitabhen ChhaganbhaCompany Sec. & Compli. Officer2025
Kishan Vinodkumar RajaIndependent Director2025
Segments — Geography
RegionRevenueShare
Domestic Sales₹173 Cr98%
Export Sales₹3 Cr2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10555353
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-13Board Meetings
forthcoming2026-08-11Board Meetings
forthcoming2026-07-30Board Meetings
bonus2026-04-24Bonus issue 1:1
split2026-04-24Stock Split From Rs.10/- to Rs.2/-
bonus2026-04-241:11:1 Bonus issue of Equity Shares
split2026-04-241:5face value change from 10 to 2
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202610200343139
20267000320102
202615002320
Substantial Acquisitions (SAST)

3 disclosure(s)

Market03/11/2025 - 04/11/2025 · 14,75,992
Market03/11/2025 - 04/11/2025 · 14,75,992
Market09/09/2025 - 11/09/2025 · 22,54,422
Company Information
Incorporated2013
ChairmanPunitkumar R Rasadia
AuditorKaushal Dave & Associates
Investor Email[email protected]
🌐 www.anlon.in

📍 101/102 Silvercoin Complex Opp, Crystal Mall Kalawad Road, Rajkot, Gujarat, 360005

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search